Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by the MT-RNR1 gene. It plays a role in metabolic regulation by activating AMPK and regulating nuclear gene expression upon metabolic stress. It has implications for treating diabetes, obesity, and age-related diseases. It translocates to the nucleus to interact with transcription factors like NRF2/NFE2L2.
Inhibits folate cycle, activates AMPK, regulates nuclear gene expression (e.g., NRF2/NFE2L2 pathway)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Open Reading Frame of the 12S rRNA Type-c (MOTS-c).